“Our Lives Are Not Misinformation
Newsweek|May 13, 2022
COVID-19 vaccines are safe for the vast majority of people. That's small consolation for the few who fall between the cracks
JOANNA BRODER
“Our Lives Are Not Misinformation

ON NOVEMBER 4, 2020, BRIANNE DRESSEN walked into a clinic in West Jordan, Utah to take part in a clinical trial for AstraZeneca's COVID19 vaccine. A few minutes after getting the shot, her arm began to tingle and her eyes felt "weird,” she says. Her symptoms soon got worse. She developed a fever and chills and her arm went numb. At one point she grew so sensitive to light and sound that she sought relief in a dark room wearing earmuffs.

By the time she got to the emergency room at the University of Utah Hospital in Salt Lake City, the numbness had spread from her feet upward to her legs. She had lost the ability to walk and could no longer control her bladder and bowels. “It was really scary," she says.

What followed was a long nightmare of seeking care for debilitating symptoms from doctors who she says were dismissive of her symptoms and dubious that a vaccine could be the cause. Although adverse effects from COVID-19 vaccines are rare, some of those who fall into that group say they have gotten short shrift by the medical establishment.

That may be due in part to the rarity of their conditions and the newness of the vaccines. The extreme politicization of the COVID-19 pandemic has also played a role. Many doctors, worried about spreading misinformation and contributing to vaccine hesitancy, have been reluctant to take complaints about severe vaccine side effects seriously, according to some people who have suffered post-COVID-19 vaccine complications. Discussion among group members about severe vaccine side-effects has been flagged as misinformation by social media platforms, particularly Facebook, making it difficult for these individuals to gather and share information with one another.

“From top-down, we are not allowed to be heard in any way, shape or form,” wrote Dressen in an email. "Our lives are not misinformation,” she added at a different point in time.

Esta historia es de la edición May 13, 2022 de Newsweek.

Comience su prueba gratuita de Magzter GOLD de 7 días para acceder a miles de historias premium seleccionadas y a más de 9,000 revistas y periódicos.

Esta historia es de la edición May 13, 2022 de Newsweek.

Comience su prueba gratuita de Magzter GOLD de 7 días para acceder a miles de historias premium seleccionadas y a más de 9,000 revistas y periódicos.

MÁS HISTORIAS DE NEWSWEEKVer todo
Mystery of Ginger Cat Is out of the Bag
Newsweek US

Mystery of Ginger Cat Is out of the Bag

The genetics behind the vibrant orange color in feline coats is finally confirmed after 112 years

time-read
3 minutos  |
January 03-17, 2025 (Double Issue)
Paris Hilton & Nicole Richie
Newsweek US

Paris Hilton & Nicole Richie

PARIS HILTON AND NICOLE RICHIE ARE READY TO BRING A LITTLE “SANASA” to the world with Peacock's Paris & Nicole: The Encore, their first project together since their reality show The Simple Life ended in 2007. What's “sanasa”? It's a song and phrase the longtime friends created as kids and popularized on The Simple Life. The show, a cultural phenomenon in the early days of reality TV, followed them over a series of blue-collar jobs. Now they're bringing it back as an opera. “I know this is just going to make people laugh, have fun, be nostalgic and just celebrate our friendship,” Hilton said. While Richie acknowledged “you can't do Simple Life again,” she said now “felt like the right time.” The famous pair also revisit some old jobs in Arkansas, like fast-food chain Sonic, where they now have drinks named for them. “I think that there is a part of our friend- ship that the show ended up showing that people connect to,” Richie said. As for this new special, Hilton is glad to do something positive for their fans. “It's been such a crazy past couple years, and I just feel like the world needs more joy.”

time-read
2 minutos  |
January 03-17, 2025 (Double Issue)
What Next for Your Drugstore?
Newsweek US

What Next for Your Drugstore?

Walgreens and Amazon are placing opposing bets on the future of retail pharmacy

time-read
6 minutos  |
January 03-17, 2025 (Double Issue)
AMERICA'S GREATEST WORKPLACES for Diversity
Newsweek US

AMERICA'S GREATEST WORKPLACES for Diversity

AS COMPANIES IN THE UNITED STATES CONTINUE TO navigate the evolving dynamics of the workplace, diversity remains a cornerstone of organizational success and social responsibility.

time-read
4 minutos  |
January 03-17, 2025 (Double Issue)
FIGHTING SPIRITS
Newsweek US

FIGHTING SPIRITS

ANDREA MCCARTHY TOLD FRIENDS and family when she gave up alcohol on January 1, 2024, that she would toast 12 months off the sauce with a drink to ring in 2025. As that anniversary approached, the Los Angeles-born content creator told Newsweek she had had a change of heart.

time-read
10 minutos  |
January 03-17, 2025 (Double Issue)
Lessons Over Lunch
Newsweek US

Lessons Over Lunch

Ninety-year-old volunteer Hugh showed me how the winter years can be full of purpose

time-read
3 minutos  |
January 03-17, 2025 (Double Issue)
Is California's Green Dream Hot Air?
Newsweek US

Is California's Green Dream Hot Air?

The state aims to rely on zero-carbon energy sources in two decades' time but has hurdles to overcome along the way

time-read
8 minutos  |
January 03-17, 2025 (Double Issue)
Power Struggle
Newsweek US

Power Struggle

As the dust settles following the toppling of Bashar al-Assad, new front lines could be drawn in Syria's old civil war

time-read
6 minutos  |
January 03-17, 2025 (Double Issue)
Downsizing Goes Bust for Boomers
Newsweek US

Downsizing Goes Bust for Boomers

Rising property costs are not just affecting young Americans—older people are ‘aging in place’ due to a dearth of affordable accessible housing

time-read
4 minutos  |
January 03-17, 2025 (Double Issue)
Ray Romano
Newsweek US

Ray Romano

\"I read about three scripts, and at the end of each there was a little twist, a little turn, [and] it was funny.\"

time-read
2 minutos  |
December 27, 2024